CCND1 and adenocarcinoma: We analyzed the prognostic value of cyclin D1 expression in all patients with NSCLC and separately in patients with SCC and adenocarcinoma, and separately in every stage, but we didn't find any statistical significant differences (Table 2 and Figure 2).